SELLAS Life Sciences Group, Inc. — Director's Dealing 2012

Jul 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2012-06-15

Reporting Person: Hillsberg Sanford (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-15	Common Stock	A	31966	—	Acquired	156376	Direct

Footnotes

F1: (1) The shares shown were issued in escrow on February 15, 2012 for the account of the reporting person at a value of $0.76 per share in payment of contingent value rights held by the reporting person, subject to release of the shares from escrow upon approval of the issuance by the stockholders of Galena Biopharma, Inc. The Galena stockholders approved the issuance on June 15, 2012.